These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 5638661)

  • 21. L-Dopa and imipramine: biochemical and behavioral interaction.
    Friedman E; Gershon S
    Eur J Pharmacol; 1972 May; 18(2):183-8. PubMed ID: 5037381
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of the adrenergic system in the action of L-DOPA on brain serotonin.
    Algeri S; Cerletti C
    Adv Biochem Psychopharmacol; 1974; 10():257-9. PubMed ID: 4846542
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on the mechanism of the L-3,4-dihydroxyphenylalanine-induced decrease in tyrosine hydroxylase activity.
    Dairman W; Udenfriend S
    Mol Pharmacol; 1972 May; 8(3):293-9. PubMed ID: 4402746
    [No Abstract]   [Full Text] [Related]  

  • 24. Norepinephrine and dopamine in the developing chick brain.
    Kobayashi K; Eiduson S
    Dev Psychobiol; 1970; 3(1):13-34. PubMed ID: 4146802
    [No Abstract]   [Full Text] [Related]  

  • 25. Correlation between brain dopamine levels and 1-dopa activity in anti-Parkinson tests.
    Horst WD; Pool WR; Spiegel HE
    Eur J Pharmacol; 1973 Mar; 21(3):337-42. PubMed ID: 4736076
    [No Abstract]   [Full Text] [Related]  

  • 26. Antagonism by dopa of morphine analgesia. A hypothesis for morphine tolerance.
    Vander Wende C; Spoerlein MT
    Res Commun Chem Pathol Pharmacol; 1972 Jan; 3(1):37-45. PubMed ID: 5030707
    [No Abstract]   [Full Text] [Related]  

  • 27. An analysis of DOPA-induced locomotor stimulation in mice with inhibited extracerebral decarboxylase.
    Przegaliński E; Kleinrok Z
    Psychopharmacologia; 1972; 23(3):279-88. PubMed ID: 4260342
    [No Abstract]   [Full Text] [Related]  

  • 28. 5-Hydroxytryptophan reversal of reserpine enhancement of audiogenic seizure susceptibility in mice.
    Boggan WO; Seiden LS
    Physiol Behav; 1973 Jan; 10(1):9-12. PubMed ID: 4540511
    [No Abstract]   [Full Text] [Related]  

  • 29. Dopa-induced locomotor stimulation after inhibition of extracerebral decarboxylase.
    Bartholini G; Blum JE; Pletscher A
    J Pharm Pharmacol; 1969 May; 21(5):297-301. PubMed ID: 4390121
    [No Abstract]   [Full Text] [Related]  

  • 30. [Avoidance conditioned reflexes in dogs with a diminished concentration of noradrenaline in the brain].
    Sokolova EV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1977; 27(3):638-40. PubMed ID: 899271
    [No Abstract]   [Full Text] [Related]  

  • 31. 3,4-Dihydroxyphenylalanine (dopa), dopamine and norepinephrine storage in the rat heart after L-dopa--further evidence for norepinephrine release.
    Landsberg L; Bruno SJ
    Biochem Pharmacol; 1973 Feb; 22(3):417-25. PubMed ID: 4687136
    [No Abstract]   [Full Text] [Related]  

  • 32. Tryptophan-induced suppression of conditioned avoidance behavior in rats.
    Engel J; Modigh K
    Adv Biochem Psychopharmacol; 1974; 11(0):405-9. PubMed ID: 4845707
    [No Abstract]   [Full Text] [Related]  

  • 33. Recovery of the amine uptake-storage mechanism in nerve granules after reserpine treatment: inhibition by axotomy.
    Andén NE; Lundborg P
    J Pharm Pharmacol; 1970 Mar; 22(3):233-5. PubMed ID: 4399497
    [No Abstract]   [Full Text] [Related]  

  • 34. Dopamine: mediator of brain polysome disaggregation after L-dopa.
    Weiss BF; Munro HN; Ordonez LA; Wurtman RJ
    Science; 1972 Aug; 177(4049):613-6. PubMed ID: 4403139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of sympathetic nerve blockade: a comparison of dopa, dopamine, and norepinephrine with their alpha-methylated analogues.
    Conradi EC; Gaffney TE; Fink DA; Vangrow JS
    J Pharmacol Exp Ther; 1965 Oct; 150(1):26-33. PubMed ID: 5853699
    [No Abstract]   [Full Text] [Related]  

  • 36. [The effect of a decrease in cerebral noradrenaline concentrations on the formation and fixation of temporary connections].
    Kruglikov RI; Orlova NV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1976; 26(1):120-6. PubMed ID: 1274427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine, noradrenaline and 5-hydroxy-tryptamine in relation to motor activity, fighting and mounting behavior. I. L-dopa and DL-threo-dihydroxyphenylserine in combination with Ro 4-4602, pargyline and reserpine.
    Benkert O; Gluba H; Matussek N
    Neuropharmacology; 1973 Mar; 12(3):177-86. PubMed ID: 4735415
    [No Abstract]   [Full Text] [Related]  

  • 38. L-DOPA induced effects on motor activity in mice after inhibition of dopamine-beta-hydroxylase.
    Strömberg U; Svensson TH
    Psychopharmacologia; 1971; 19(1):53-60. PubMed ID: 5089105
    [No Abstract]   [Full Text] [Related]  

  • 39. The cardiovascular pharmacology of L(--)-dopa: peripheral and central effects.
    Osborne MW; Wenger JJ; Willems W
    J Pharmacol Exp Ther; 1971 Sep; 178(3):517-28. PubMed ID: 5571901
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of DOPA on the spinal cord. 2. A pharmacological analysis.
    Andén NE; Jukes MG; Lundberg A
    Acta Physiol Scand; 1966; 67(3):387-97. PubMed ID: 5967602
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.